Efficient delivery of therapeutic small nucleic acids to prostate cancer cells using ketal nucleoside lipid nanoparticles

Journal of Controlled Release

Volumn 172, Issue 3, 2013, Pages 954-961

  Luvino, Delphine ^b,c   Khiati, Salim ^a,b   Oumzil, Khalid ^a,b   Rocchi, Palma ^d   Camplo, Michel ^c   Barthélémy, Philippe ^a,b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b INSERM U869   (France)

^c AIX MARSEILLE UNIVERSITÉ   (France)

^d AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Antisense; Drug delivery; Nucleoside lipids; Prostate cancer; siRNA

Indexed keywords

ANTISENSE; ANTISENSE OLIGONUCLEOTIDES; ELECTRONIC MICROSCOPY; ELECTROPHORESIS EXPERIMENTS; HUMAN PROSTATE CANCER; PROSTATE CANCER CELLS; PROSTATE CANCERS; SIRNA;

ASSAYS; CELL CULTURE; CHEMOTHERAPY; DISEASES; DRUG DELIVERY; ELECTROPHORESIS; KETONES; LIPIDS; LIPOSOMES; NUCLEIC ACIDS;

BIOMOLECULES;

ABIRATERONE; ACETAL; ETHIDIUM BROMIDE; LIPID; LIPOFECTAMINE; NANOPARTICLE; NUCLEOSIDE; OLEIC ACID ETHYL ESTER;

AQUEOUS SOLUTION; ARTICLE; CANCER CELL CULTURE; CANCER GENE THERAPY; CELL SURVIVAL; COMPLEX FORMATION; CONTROLLED STUDY; DOWN REGULATION; ENDOCYTOSIS; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTERNALIZATION; MALE; NONVIRAL GENE THERAPY; NUCLEIC ACID TRANSPORT; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROSTATE CANCER; REPORTER GENE; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

ANTISENSE; DRUG DELIVERY; NUCLEOSIDE LIPIDS; PROSTATE CANCER; SIRNA;

CELL LINE, TUMOR; HUMANS; LIPIDS; LIPOSOMES; MALE; NANOPARTICLES; NUCLEOSIDES; PROSTATIC NEOPLASMS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84887190278     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.09.006     Document Type: Article

References (32)

1. J. Jin, K.H. Bae, H. Yang, S.J. Lee, H. Kim, Y. Kim, K.M. Joo, S.W. Seo, T.G. Park, and D.H. Nam In vivo specific delivery of c-Met siRNA to glioblastoma using cationic solid lipid nanoparticles Bioconjug. Chem. 22 2011 2568 2572
2. M. Sioud, and A. Mobergslien Efficient siRNA targeted delivery into cancer cells by gastrin-releasing peptides Bioconjug. Chem. 23 2012 1040 1049
3. G. Dorn, S. Patel, G. Wotherspoon, M. Hemmings-Mieszczak, J. Barclay, F.J. Natt, P. Martin, S. Bevan, A. Fox, P. Ganju, W. Wishart, and J. Hall siRNA relieves chronic neuropathic pain Nucleic Acids Res. 32 2004 e49
4. C.D. Novina, and P.A. Sharp The RNAi revolution Nature 430 2004 161 164 (Pubitemid 38902417)
5. M. Raouane, D. Desmaële, G. Urbinati, L. Massaad-Massade, and P. Couvreur Lipid conjugated oligonucleotides: a useful strategy for delivery Bioconjug. Chem. 23 2012 1091 1104
6. O.M. Merkel, M. Zheng, H. Debus, and T. Kissel Pulmonary gene delivery using polymeric nonviral vectors Bioconjug. Chem. 23 2012 3 20
7. C. Troiber, and E. Wagner Nucleic acid carriers based on precise polymer conjugates Bioconjug. Chem. 22 2011 1737 1752
8. Y.C. Tseng, S. Mozumdar, and L. Huang Adv. Drug Deliv. Rev. 61 2009 721 731
9. T. Kaiden, E. Yuba, A. Harada, Y. Sakanishi, and K. Kono Dual signal-responsive liposomes for temperature-controlled cytoplasmic delivery Bioconjug. Chem. 22 2011 1909 1915
10. S. Asayama, T. Kumagai, and H. Kawakami Synthesis and characterization of methylated poly(l-histidine) to control the stability of its siRNA polyion complexes for RNAi Bioconjug. Chem. 23 2012 1437 1442
11. H. Takemoto, K. Miyata, T. Ishii, S. Hattori, S. Osawa, N. Nishiyama, and K. Kataoka Accelerated polymer-polymer click conjugation by freeze-thaw treatment Bioconjug. Chem. 23 2012 1503 1506
12. H. Jin, J.F. Lovell, J. Chen, Q. Lin, L. Ding, K.K. Ng, R.K. Pandey, M. Manoharan, Z. Zhang, and G. Zheng Mechanistic insights into LDL nanoparticle-mediated siRNA delivery Bioconjug. Chem. 23 2012 33 41
13. R.L. Juliano, X. Ming, and O. Nakagawa Cellular uptake and intracellular trafficking of antisense and siRNA oligonucleotides Bioconjug. Chem. 23 2012 147 157
14. S.C. Semple, A. Akinc, J. Chen, A.P. Sandhu, B.L. Mui, C.K. Cho, D.W.Y. Sah, D. Stebbing, E.J. Crosley, E. Yaworski, I.M. Hafez, J.R. Dorkin, J. Qin, K. Lam, K.G. Rajeev, K.F. Wong, L.B. Jeffs, L. Nechev, M.L. Eisenhardt, M. Jayaraman, M. Kazem, M.A. Maier, M. Srinivasulu, M.J. Weinstein, Q. Chen, R. Alvarez, S.A. Barros, S. De, S.K. Klimuk, T. Borland, V. Kosovrast, W.L. Cantley, Y.K. Tam, M. Manoharan, M.A. Ciufolini, M.A. Tracy, A. de Fougerolles, I. MacLachlan, P.R. Cullis, T.D. Madden, and M.J. Hope Rational design of cationic lipids for siRNA delivery Nat. Biotechnol. 28 2010 172 176
15. Y. Sato, H. Hatakeyama, Y. Sakurai, M. Hyod, H. Akita, and H. Harashima A pH-sensitive cationic lipid facilitates the delivery of liposomal siRNA and gene silencing activity in vitro and in vivo J. Control. Release 163 2012 267 276
16. P. Chabaud, M. Camplo, D. Payet, G. Serin, L. Moreau, P. Barthélémy, and M.W. Grinstaff Cationic nucleoside lipids derived for gene delivery Bioconjug. Chem. 17 2006 466 472
17. C. Ceballos, C.H. Prata, S. Giorgio, D. Payet, P. Barthélé my, M.W. Grinstaff, and M. Camplo Cationic nucleoside lipids possessing a 3-nitropyrrole universal base for siRNA delivery Bioconjug. Chem. 20 2009 193 196
18. C. Ceballos, S. Khiati, C.A. Prata, X.X. Zhang, S. Giorgio, P. Marsal, M.W. Grinstaff, P. Barthélémy, and M. Camplo Cationic nucleoside lipids derived from universal bases: a rational approach for siRNA transfection Bioconjug. Chem. 21 2010 1062 1069
19. N. Taib, A. Aimé, L. Moreau, M. Camplo, S. Houmadi, B. Desbat, M. Laguerre, M.W. Grinstaff, I. Bestel, and P. Barthélémy Formation of supramolecular systems via directed nucleoside-lipid recognition J. Colloid Interface Sci. 377 2012 122 130
20. L. Moreau, M. Camplo, M. Wathier, N. Taib, M. Laguerre, I. Bestel, M.W. Grinstaff, and P. Barthélémy Real time imaging of supramolecular assembly formation via programmed nucleolipid recognition J. Am. Chem. Soc. 130 2008 14454 14455
21. T. Pinnarat, and P.E. Savage Non catalytic esterification of oleic acid in ethanol J. Supercrit. Fluids 53 2010 53 59
22. L. Moreau, P. Barthélémy, M. El Maataoui, and M.W. Grinstaff Supramolecular assemblies of nucleoside phosphocholine amphiphiles J. Am. Chem. Soc. 126 2004 7533 7539 (Pubitemid 38781487)
23. D.P. Petrylak, C.M. Tangen, M.H. Hussain, P.N. Lara Jr., J.A. Jones, M.E. Taplin, P.A. Burch, D. Berry, C. Moinpour, M. Kohli, M.C. Benson, E.J. Small, D. Raghavan, and E.D. Crawford Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer N. Engl. J. Med. 351 2004 1513 1520 (Pubitemid 39315318)
24. I.F. Tannock, R. de Wit, W.R. Berry, J. Horti, A. Pluzanska, K.N. Chi, S. Oudard, C. Théodore, N.D. James, I. Turesson, M.A. Rosenthal, and M.A. Eisenberger Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer N. Engl. J. Med. 351 2004 1502 1512 (Pubitemid 39315317)
25. C.S. Matos, A.L. de Carvalho, R.P. Lopes, and M.P. Marques New strategies against prostate cancer-Pt(II)-based chemotherapy Curr. Med. Chem. 19 2012 4678 4687
26. M. Malhotra, R. Dhingra, T. Sharma, A. Deep, B. Narasimhan, P. Phogat, and P.C. Sharma Cabazitaxel: a novel drug for hormone-refractory prostate cancer Mini-Rev. Med. Chem. 12 2012 1 6
27. H. Miyake, M. Pollak, and M. Gleave Castration-induced up-regulation of insulin-like growth factor binding protein-5 potentiates insulin-like growth factor-I activity and accelerates progression to androgen independence in prostate cancer models Cancer Res. 60 2000 3058 3064 (Pubitemid 30395835)
28. C. Andrieu, D. Taieb, V. Baylot, S. Ettinger, P. Soubeyran, A. De-Thonel, C. Nelson, C. Garrido, A. So, L. Fazli, F. Bladou, M. Gleave, J.L. Iovanna, and P. Rocchi Heat Shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through, eIF4E Oncogene 29 2010 1883
29. J. Acunzo, M. Katsogiannou, and P. Rocchi Small heat shock proteins HSP27 (HspB1), αB-crystallin (HspB5) and HSP22 (HspB8) as regulators of cell death Int. J. Biochem. Cell Biol. 44 2012 1622 1631
30. M.E. Gleave, and B.P. Monia Antisense therapy for cancer Nat. Rev. Cancer 5 2005 468
31. P. Rocchi, A. So, S. Kojima, M. Signaevsky, E. Beraldi, L. Fazli, A. Hurtado-Coll, K. Yamanaka, and M. Gleave Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer Cancer Res. 64 2004 6595 6602 (Pubitemid 39297919)
32. M. Kamada, A. So, M. Muramaki, P. Rocchi, E. Beraldi, and M. Gleave Hsp27 knockdown using nucleotide-based therapies inhibit tumor growth and enhance chemotherapy in human bladder cancer cells Mol. Cancer Ther. 6 2007 299 308 (Pubitemid 46206694)